Studies have shown the downregulation of the PP2A-B55 regulatory subunit in non-small cell lung carcinomas [75, 76], however, the underlying mechanism of ENSA and its role in PP2A modulation in lung disease remains poorly explored. The gene discussed is PTPA; the disease is non-small cell lung carcinoma.